Heiko Jessen

10.9k total citations · 2 hit papers
71 papers, 4.8k citations indexed

About

Heiko Jessen is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Heiko Jessen has authored 71 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 35 papers in Virology and 28 papers in Epidemiology. Recurrent topics in Heiko Jessen's work include HIV Research and Treatment (35 papers), HIV/AIDS Research and Interventions (27 papers) and HIV/AIDS drug development and treatment (24 papers). Heiko Jessen is often cited by papers focused on HIV Research and Treatment (35 papers), HIV/AIDS Research and Interventions (27 papers) and HIV/AIDS drug development and treatment (24 papers). Heiko Jessen collaborates with scholars based in Germany, United States and Canada. Heiko Jessen's co-authors include Joel M. Palefsky, Richard M. Haupt, Edson Duarte Moreira, Anna R. Giuliano, Scott Vuocolo, Dalya Güriş, Stephen E. Goldstone, Richard J. Hillman, J. Brooke Marshall and Carlos Aranda and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Heiko Jessen

70 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

2011 821 citations Anna R. Giuliano, Joel M. Palefsky et al. profile →
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

2011 650 citations Joel M. Palefsky, Anna R. Giuliano et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Heiko Jessen	2.6k	1.7k	1.5k	1.3k	1.2k	71	4.8k
Laurent Bélec	2.2k 0.8×	2.1k 1.3×	2.4k 1.6×	934 0.7×	269 0.2×	262	5.7k
Simon Beddows	1.6k 0.6×	1.6k 1.0×	1.0k 0.7×	955 0.7×	557 0.5×	88	3.6k
Francis K. Lee	2.6k 1.0×	636 0.4×	1.1k 0.7×	609 0.5×	383 0.3×	46	4.0k
Danielle Rouleau	1.8k 0.7×	1.1k 0.6×	1.1k 0.7×	294 0.2×	896 0.8×	66	2.9k
Rhoda L. Ashley	6.1k 2.3×	1.0k 0.6×	1.9k 1.2×	678 0.5×	791 0.7×	89	7.6k
Stacy Selke	5.4k 2.1×	982 0.6×	1.9k 1.3×	639 0.5×	321 0.3×	108	6.4k
Stephen Follansbee	3.1k 1.2×	892 0.5×	2.0k 1.3×	292 0.2×	422 0.4×	47	4.4k
Kenneth H. Fife	2.6k 1.0×	563 0.3×	897 0.6×	562 0.4×	779 0.7×	93	3.8k
Daniel R. Lucey	1.1k 0.4×	1.3k 0.7×	1.3k 0.8×	1.7k 1.3×	289 0.3×	76	4.2k
Thumbi Ndung’u	2.1k 0.8×	4.0k 2.3×	3.4k 2.2×	2.7k 2.1×	455 0.4×	273	7.6k

Countries citing papers authored by Heiko Jessen

Since Specialization

Citations

This map shows the geographic impact of Heiko Jessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiko Jessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiko Jessen more than expected).

Fields of papers citing papers by Heiko Jessen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiko Jessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiko Jessen. The network helps show where Heiko Jessen may publish in the future.

Co-authorship network of co-authors of Heiko Jessen

This figure shows the co-authorship network connecting the top 25 collaborators of Heiko Jessen. A scholar is included among the top collaborators of Heiko Jessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiko Jessen. Heiko Jessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crowell, Trevor A., Haoyu Qian, Carsten Tiemann, et al.. (2021). Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort. AIDS Research and Therapy. 18(1). 52–52. 3 indexed citations

Koppe, Uwe, Ulrich Marcus, Stefan Albrecht, et al.. (2021). Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany. BMC Public Health. 21(1). 159–159. 27 indexed citations

Zimmermann, Ruth, Mirko Faber, Sandra Dudareva, et al.. (2020). Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventions. International Journal of Infectious Diseases. 103. 146–153. 16 indexed citations

Machnowska, Patrycja, Karolin Meixenberger, Daniel Schmidt, et al.. (2019). Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort. PLoS ONE. 14(1). e0209605–e0209605. 34 indexed citations

Li, Yanpeng, Binlian Sun, Stefan Eßer, et al.. (2017). Expression Pattern of Individual IFNA Subtypes in Chronic HIV Infection. Journal of Interferon & Cytokine Research. 37(12). 541–549. 17 indexed citations

Toyoda, Mako, Yoko Ogata, Yosuke Maeda, et al.. (2015). Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors. Journal of Virology. 89(18). 9639–9652. 21 indexed citations

Brumme, Zabrina L., et al.. (2015). Dynamic range of Nef-mediated evasion of HLA class II-restricted immune responses in early HIV-1 infection. Biochemical and Biophysical Research Communications. 463(3). 248–254. 7 indexed citations

Vaidya, Sagar A., Hendrik Streeck, Noor Beckwith, et al.. (2013). Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection. Retrovirology. 10(1). 139–139. 10 indexed citations

Gunsenheimer‐Bartmeyer, Barbara, Kathrin Keeren, Christian Kollan, et al.. (2010). Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort. PLoS ONE. 5(10). e12718–e12718. 49 indexed citations

10.

Vardas, Eftyhia, Anna R. Giuliano, Joel M. Palefsky, et al.. (2010). External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents. The Journal of Infectious Diseases. 203(1). 58–65. 86 indexed citations

11.

Palefsky, Joel M., Anna R. Giuliano, Edson Duarte Moreira, et al.. (2010). Prevalence of and Risk Factors for Human Papillomavirus (HPV) Infection Among HIV-Seronegative Men Who Have Sex With Men. The Journal of Infectious Diseases. 203(1). 66–74. 150 indexed citations

12.

Brockman, Mark A., Douglas S. Kwon, David F. Pavlik, et al.. (2009). IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood. 114(2). 346–356. 225 indexed citations

13.

Wolf, Eva, Heiko Jessen, Knud Schewe, et al.. (2009). Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort. European journal of medical research. 14(7). 277–83. 18 indexed citations

14.

Schneidewind, Arne, Zabrina L. Brumme, Chanson J. Brumme, et al.. (2008). Transmission and Long-Term Stability of Compensated CD8 Escape Mutations. Journal of Virology. 83(8). 3993–3997. 49 indexed citations

15.

Oh, Djin‐Ye, Stefan Taube, Osamah Hamouda, et al.. (2008). A Functional Toll‐Like Receptor 8 Variant Is Associated with HIV Disease Restriction. The Journal of Infectious Diseases. 198(5). 701–709. 91 indexed citations

16.

Poggensee, G, Claudia Kücherer, B Bieniek, et al.. (2007). Impact of transmission of drug‐resistant HIV on the course of infection and the treatment success. Data from the German HIV‐1 Seroconverter Study. HIV Medicine. 8(8). 511–519. 43 indexed citations

17.

Morozov, Vladimir A., et al.. (2007). Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon®) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy. Virus Genes. 35(2). 167–174. 14 indexed citations

18.

Streeck, Hendrik, Heiko Jessen, Galit Alter, et al.. (2006). Immunological and Virological Impact of Highly Active Antiretroviral Therapy Initiated during Acute HIV‐1 Infection. The Journal of Infectious Diseases. 194(6). 734–739. 67 indexed citations

19.

Lori, Franco, Heiko Jessen, Judy Lieberman, et al.. (1999). Immune Restoration by Combination of a Cytostatic Drug (Hydroxyurea) and Anti-HIV Drugs (Didanosine and Indinavir). AIDS Research and Human Retroviruses. 15(7). 619–624. 28 indexed citations

20.

Lori, Franco, Heiko Jessen, Judy Lieberman, et al.. (1999). Treatment of Human Immunodeficiency Virus Infection with Hydroxyurea, Didanosine, and a Protease Inhibitor before Seroconversion Is Associated with Normalized Immune Parameters and Limited Viral Reservoir. The Journal of Infectious Diseases. 180(6). 1827–1832. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact